{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:52:36Z","timestamp":1781301156075,"version":"3.54.1"},"reference-count":0,"publisher":"MJH Life Sciences","issue":"3512","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.46883\/2021.25920935","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T15:26:49Z","timestamp":1641396409000},"page":"804-811","source":"Crossref","is-referenced-by-count":2,"title":["Real-World Assessment of Patient Care and Practice Efficiency With the Introduction of Subcutaneous Rituximab"],"prefix":"10.46883","member":"25947","published-online":{"date-parts":[[2021,12,23]]},"container-title":["ONCOLOGY"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T15:26:50Z","timestamp":1641396410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cancernetwork.com\/view\/real-world-assessment-of-patient-care-and-practice-efficiency-with-the-introduction-of-subcutaneous-rituximab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":0,"issue-title":["December 2021"],"journal-issue":{"issue":"3512","published-online":{"date-parts":[[2021,12,9]]},"published-print":{"date-parts":[[2021,12,9]]}},"URL":"https:\/\/doi.org\/10.46883\/2021.25920935","relation":{},"ISSN":["0890-9091"],"issn-type":[{"value":"0890-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}